A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

ClinicalTrials.gov ID: NCT00002362

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00002362. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:06 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label Superiority Trial Comparing Emtricitabine to Abacavir Within a Triple Drug Combination in Antiretroviral-Drug Naive HIV-1 Infected Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will look at whether emtricitabine is as safe and effective as abacavir (ABC) when taken with stavudine (d4T) and efavirenz (EFV) in patients who have never taken anti-HIV drugs.

Study identification

NCT ID: NCT00002362
Recruitment status: Suspended
Study type: Interventional
Phase: Phase 3
Lead sponsor: Triangle Pharmaceuticals; Industry
Enrollment: Not listed

Conditions and interventions

Conditions

HIV Infections

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 1999 (Type not available)
Primary completion: Not listed
Completion: Not listed
Last update posted: Jun 24, 2005

Started 1999

United States locations

U.S. sites: 10
U.S. states: 6
U.S. cities: 9

Facility	City	State	ZIP	Site status
Ctr for AIDS Research / Education and Service (CARES)	Sacramento	California	95814	—
San Francisco Veterans Administration Med Ctr	San Francisco	California	94121	—
Gary Richmond MD	Fort Lauderdale	Florida	33316	—
Northstar Med Clinic	Chicago	Illinois	60657	—
South Jersey Infectious Diseases Inc	Somers Point	New Jersey	08244	—
North Shore Univ Hosp / Div of Infectious Diseases	Manhasset	New York	11030	—
Univ of Texas Southwestern Med Ctr of Dallas	Dallas	Texas	75235	—
Houston Clinical Research Network	Houston	Texas	77006	—
Univ of Texas / Med School at Houston	Houston	Texas	77030	—
Univ of Texas Health Sciences Ctr	San Antonio	Texas	78284	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00002362, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 24, 2005 · Synced Nov 14, 2026